XML 13 R2.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Balance Sheet - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Assets    
Cash and cash equivalent $ 289,580
Prepaid expenses 60,506
Deferred offering costs associated with initial public offering 131,602
Total current assets 350,086 131,602
Marketable securities 88,485,688
Total Assets 88,835,774 131,602
Liabilities and Shareholders' Deficit    
Accounts payable and accrued expenses 660,725 3,124
Total current liabilities 660,725 114,314
Deferred underwriting fee 3,450,000
Sponsor Loan Payable 500,000
Total non-current liabilities 3,950,000
Total Liabilities 4,610,725 114,314
Commitments
Shareholders' Deficit    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital 24,698
Accumulated deficit (4,260,968) (7,712)
Total Shareholders' Deficit (4,260,639) 17,288
Total Liabilities, and Shareholders' Deficit 88,835,774 131,602
Related Party    
Liabilities and Shareholders' Deficit    
Due to related party 111,190
Class A Ordinary Shares    
Liabilities and Shareholders' Deficit    
Class A ordinary shares, $0.0001 par value; 8,625,000 shares subject to possible redemption at $10.26 per share as of September 30, 2025 (zero as of December 31, 2024) 88,485,688
Shareholders' Deficit    
Ordinary shares, value 230
Class B Ordinary Shares    
Shareholders' Deficit    
Ordinary shares, value [1] $ 99 $ 302
[1] December 31, 2024 includes up to 393,750 Class B ordinary shares that were subject to forfeiture until the over-allotment option was exercised in full by the underwriters subsequent to December 31, 2024 (Note 5).